Cargando…
Decreased suicide rates in recent antidepressant clinical trials
RATIONALE: The last systematic analysis of suicidality in antidepressant clinical trials submitted for approval by the US Food and Drug Administration was in 2000. Given the attention to suicide and antidepressants in the early 2000s, the authors aimed to evaluate if there have been any changes in s...
Autores principales: | Khan, Arif, Fahl Mar, Kaysee, Gokul, Sagarika, Brown, Walter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920087/ https://www.ncbi.nlm.nih.gov/pubmed/29480436 http://dx.doi.org/10.1007/s00213-018-4856-1 |
Ejemplares similares
-
The conundrum of depression clinical trials: one size does not fit all
por: Khan, Arif, et al.
Publicado: (2018) -
Does the rising placebo response impact antihypertensive clinical trial outcomes? An analysis of data from the Food and Drug Administration 1990-2016
por: Khan, Arif, et al.
Publicado: (2018) -
Magnitude of change with antidepressants and placebo in antidepressant clinical trials using structured, taped and appraised rater interviews (SIGMA-RAPS) compared to trials using traditional semi-structured interviews
por: Khan, Arif, et al.
Publicado: (2014) -
Association of Recent Fatherhood With Antidepressant Treatment Initiation Among Men in the United Kingdom
por: Smith, Holly Christina, et al.
Publicado: (2023) -
Suicide Rates and Antidepressant Prescribing: A Casual or Causal Relationship?
por: Baune, Bernhard, et al.
Publicado: (2006)